Like AChE, the enzyme BChE is involved in the hydrolysis of the neurotransmitter ACh and was therefore proposed as a viable therapeutic target in AD, a disorder characterized by a cholinergic deficit. The gene discussed is ACHE; the disease is Alzheimer disease.